top of page
News, Events and Updates
Search
Mar 30, 2021
Anavex Life Sciences Reports Data Review by the Independent Data Safety Monitoring Board
Mar 16, 2021
Anavex Life Sciences Reports ANAVEX®2-73 featured as a Disease-Modifying Small Molecule in Trials
Aug 4, 2020
Anavex Life Sciences Receives TGA Special Access Scheme Approval for ANAVEX®2-73 for Alzheimer’s
Jun 3, 2020
Anavex Life Sciences Receives Approval from Health Canada & UK MHRA Expanding Phase 2b/3 ANAVEX®2-73
1
2
3
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
